Oral granular cell tumours: A histological and immunocytochemical study

Journal of Oral Pathology and Medicine

Volumn 26, Issue 4, 1997, Pages 164-169

  Williams, Hazel K ^a   Williams, David M ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

granular cell tumour; neuroendocrine tumours; neurone specific enolase; protein gene product 9.5

Indexed keywords

EID: 0031128334     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1997.tb00452.x     Document Type: Article

References (38)

1. LUCAS RB. Pathology of tumours of the oral tissues, 4th edn. Edinburgh: Churchill Livingstone, 1984: 229-36.
2. KHANSUR T, BALDUCCI L, TAVASSOLI M. Granular cell tumour. Clinical spectrum of the benign and malignant entity. Cancer 1987; 60:220-2.
3. MOSCOVIC EA, AZAR HA. Multiple granular cell tumours ('myoblastomas'). Case report with electron microscopic observations and review of the literature. Cancer 1967; 20 : 2032-47.
4. ABRIKOSSOF A. (ber Myome, ausgehend von der quergestreiften willkürlichen muskulatur. Virch Arch A 1926; 260: 215-33.
5. AZZOPARDI JG Histogenesis of the granular cell myoblastoma. J Pathol Bact 1956; 71: 85-94.
6. FISHER ER, WECHSLER H. Granular cell myoblastoma - a misnomer. Electron microscopic and histochemical evidence concerning its Schwann cell derivation and nature (granular cell schwannoma). Cancer 1962; 15: 936-54.
7. STEWART CM, WATSON RE, EVERSOLE LR, FISCHLSCHWEIGER W, LEIDER AS. Oral granular cell tumours: a clinicopathologic and immunocytochemical study. Oral Surg Oral Med Oral Pathol 1988; 65: 427-35.
8. BULEY ID, GATTER KC, KELLY PMA, HERYET A, MILLARD PR. Granular cell tumours revisited. An immunohistochemical and ultrastructural study. Histopathology 1988; 12: 263-74.
9. MITTAL KR, TRUE LD. Origin of granules in granular cell tumour. Intracellular myelin formation with autodigestion. Arch Pathol Lab Med 1988; 112: 302-3.
10. MIETTINEN M, LEHTONEN E, LEHTOLA H, EKBLOM P, LEHTO V-P, VIRIANEN I. Histogenesis of granular cell tumour - an immunohistochemical and ultrastructural study. J Pathol 1984; 142: 221-9.
11. SLOOTWEG P, DE WILDE P, Voous P, RAMAEKERS F. Oral granular cell lesions. An immunohistochemical study with emphasis on intermediate sized filaments proteins. Virch Arch A 1983; 402. 35-45.
12. OPHIR D, LIFSCHITZ-MERCER B, CZERNOBILSKY B. Expression of intermediate filaments and stromal proteins in granular cell tumour of the tongue. Oral Surg Oral Med Oral Pathol 1988; 66: 689-96.
13. MACKIE RM, CAMPBELL I, TURBITT M. Use of NK1C-3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol 1984; 37: 367-72.
14. LEADER M, COLLINS M, PATEL J, HENRY K. Antineurone specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity. J Clin Pathol 1986; 39: 1186-92.
15. PEARSE AGE, TAKOR T. Neuroendocrine embryology and the APUD concept. Clin Endocrinol (Oxf) 1976; 5: (suppl): 229S-44S.
16. GOULD RP. The APUD cell system. In: ANTHONY PP, WOOLF N eds. Recent advances in histopathology: vol 10. London: Churchill Livingstone. 1978; 1-22.
17. WILLIAMS HK, CANNELL H, SILVESTER K, WILLIAMS DM. Neurilemmoma of the head and neck. Br J Oral Maxillofac Surg 1993; 31: 32-5.
18. DISBREY BD, RACK JH. Histological laboratory methods. Edinburgh: E & S Livingstone, 1970: 245-7.
19. JACKSON P, THOMPSON RJ. The demonstration of new human brain specific proteins by high resolution two-dimensional polyacrylamide gel electrophoresis. J Neurol Sci 1981; 49: 429-38.
20. RODE J, DHILLON AP, DORAN JF, JACKSON P, THOMPSON RJ. PGP 9.5 a new marker for human neuroendocrine tumours. Histopathology 1985; 9: 147-58.
21. SPRINGALL DR, IBRAHIM NB, RODE J, SHARPE MS, BLOOM SR, POLAK JM. Endocrine differentiation of extra-pulmonary small cell carcinoma demonstrated by immunohistochemistry using antibodies to PGP 9.5, neurone-specific enolase and the C-flanking peptide of human probombesin. J Pathol 1986; 150: 151-62.
22. RODE J, DHILLON AP, PAPEDOKI L. Immunohistochemical staining of granular cell tumour for neurone specific enolase: evidence in support of a neural origin. Diagn Histopathol 1982; 5: 205-11.
23. HARRIS MD, MOORE IE, STEART PV, WELLER RO. Protein gene product (PGP) 9.5 as a reliable marker in primitive neuroectodermal tumours - an immunohistochemical study of 21 childhood cases. Histopathology 1990; 16: 271-7.
24. CARTER RL, AL-SAM SZ, CORBETT RP, CLINTON S. A comparative study of immunohistochemical staining for neurone-specific enolase, protein gene product 9.5 and S100 protein in neuroblastoma, Ewings sarcoma and other round cell tumours in children. Histopathology 1990; 16: 461-7.
25. DAPRADA M, BERNEIS KH, PLETSCHER A. Storage of catecholamines in adrenal medullary granules: formation of aggregates with nucleotides. Life Sci 1971; 10: 639-46.
26. LLOYD RV, BLAIVAS M, WILSON BS. Distribution of chromogranin & S100 protein in normal and abnormal adrenal medullary tissues. Arch Pathol Lab Med 1985; 109: 633-5.
27. KIMURA N, SASANO N. YAMADA R, SATOH J. Immunohistochemical study of chromogranin in 100 cases of phaeochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour. Virchows Arch A 1988; 413: 33-8.
28. HAGN C, SCHMID KW, FISCHER-COLBRIE R, WINTELER H. Chromogranin A, B, and C in human adrenal medulla and endocrine tissues. Lab. Invest 1986; 55: 405-11.
29. KLIEWER KE, WEN DR, CANCILLA PA, COCHRAN AJ. Paragangliomas: assessment of prognosis by histologic, immunocytochemical and ultrastructural techniques. Human Pathol 1989; 29-39.
30. MANGER WM, GIFFORD RW eds. Phaeochromocytoma. New York: Springer-Verlag, 1977.
31. LFNNOILA RI, LACK EE, STEINBERG SM, REISER HR. Decreased expression of neuropeptides in malignant paraganglioinas. An immunohistochemical study. Hum Pathol 1988; 19: 41-50.
32. MIRCHANDANI R, SCIUBBA JJ, MIR R. Granular cell lesions of the jaws and oral cavity: a clinicopathologic, immunohistochemical and ultrastructural study. J Oral Maxillofac Surg 1989; 47: 1248-55.
33. CLARK HB, MINESKY JJ, AGRAWAL D, AGRAWAL HC. Myelin basic protein and P2 protein are not immunohistochemical markers for Schwann cell neoplasms. A comparative study using antisera to S100, P2 and myelin basic protein. Am J Pathol 1985; 121: 96-401.
34. REIFENBERGER G, SZYMÀS J, WECHSLER W. Differential expression of glial and neuronal-associated antigens in human tumours of the central and peripheral nervous system. Acta Neuropathol 1987; 74: 105-23.
35. CRUZ-SANCHEZ FF, HAUNSTEIN J, Rossi ML, CERVOS-NAVARRO J, HUGHES JT. Ependymoblastoma: a histological, immunohistological and ultrastructural study of five cases. Histopathology 1988; 12: 17-27.
36. BARRETT AW, SCULLY C. S100 protein in oral biology and pathology. J Oral Pathol Med 1994; 23: 433-40.
37. ALLEN I. Demyelinating disease. In: ADAMS JH, CORSELLIS JAN, DUCHEN LW eds. Greenfield's neuropathology. London: Edward Arnold, 1984; 338-40.
38. SOBEL MJ, MARQUET E, AVRIN E, SCHWARZ R. Granular cell myoblastoma: an electron microscopic and cytochemical study illustrating the genesis of granules and aging of myoblastoma cells. Am J Pathol 1971;65:59-78.